Considering that leptin and/or leptin receptor levels could be dysregulated in BC patients and that genetic variation contributes to BC risk, this report investigated the association of leptin, leptin receptor, and single nucleotide polymorphisms in their genes (LEP and LEPR) with the risk of BC. Here, LEPR is linked to breast cancer.